Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Humoral response against spike protein enhanced by fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects

Published:2023-11-16 Issue:3 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kato Hideaki¹^ORCID,Kurosawa Takayuki²,Horikawa Kazuo³,Kimura Yayoi³,Miyakawa Kei⁴,Ryo Akihide⁵,Goto Atsushi⁶

Affiliation:

1. Infection Prevention and Control Department, Yokohama City University Hospital, Yokohama, Japan

2. Clinical Laboratory Department, Yokohama City University Hospital, Yokohama, Japan

3. Advanced Medical Research Center, Yokohama City University, Yokohama, Japan

4. Research Center for Influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, Japan

5. Department of Virology III, National Institute of Infectious Diseases, Musashimurayama, Japan

6. Department of Public Health, Yokohama City University School of Medicine, Yokohama, Japan

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2278376

Reference24 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination

3. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants

4. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave

5. Fourth Dose of BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humoral response against spike protein and fifth and sixth COVID-19 mRNA vaccine in the uninfected and infected subjects: What should be for the seventh dose?;Human Vaccines & Immunotherapeutics;2023-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3